Landing in Tenerife is a bit like landing on an ornamental placemat. Wherever you look, there are swatches of green, indicating dense forests, the blue of the ocean, red-roofed homes, and, looming over it all, Pico del Teide, the volcanic peak rising like a phoenix from the land. My Tenerife adventure begins in its capital city, Santa Cruz, which is also the shared capital of Spain's Canary Islands-there are seven main islands. Before taking off on a road trip to explore the highlights of the island, Ilinger in cosmopolitan Santa Cruz.
Considerable effort has been put in to make this city a dynamic hub. Emblematic buildings like the Tenerife Espacio de las Artes, designed by the Pritzker prize laureates and Swiss architects Herzog and de Meuron, illustrate the city's forwardthinking spirit. Cutting edge and contemporary in structure, design and thought, this arts space is defined by a large lightfilled gallery, hosts temporary exhibitions and displays such stellar work as the art of local surrealist master Oscar Dominguez on permanent display. The library that's part of this complex is as worthy of a visit, with its inviting open plan space and cubicles to read and relax.
If you have time for just one more museum, let it be the Museo de Naturaleza y Arqueologia. Located in a magnificently restored former civil hospital, one section of the museum offers an overview of the island's flora, fauna and geology. Key to the viewing experience is the section that deals with the lifestyle and culture of the Guanche, the original inhabitants of the land. The Guanches, believed to be related to the light-skinned Berbers from North Africa, are thought to have arrived on the island sometime in the first millennium BCE. Prehistoric skulls sit along tools, jewellery and objects of daily life, offering insight into the little-known life of these original inhabitants.
This story is from the February 04, 2023 edition of Mint Mumbai.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the February 04, 2023 edition of Mint Mumbai.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Sign In
Think Tesla Is In Trouble? Pity Even More Its Wannabe EV Rivals
The combined market value of six prominent wannabes hit 400bn in 2021, but today they are worth 65bn
Has The Growth Of Our Economy Translated Into Domestic Jobs?
While the covid shock and other setbacks got in the way, data indicates that employment in India is on a firm recovery path
How not to blow a major chunk of your travel budget on visas
Rejection of visas can impact your travel costs, especially when you have to cancel flight and hotel bookings
Ghosh won't stay on Bandhan Bank board
Board may even look at appointing an interim CEO post his tenure
Aakash names Deepak Mehrotra as managing director and CEO
Aakash Educational Services Ltd (AESL), a subA sidiary of embattled startup Byju's, has appointed Deepak Mehrotra as its managing director and chief executive officer.
Market cap of BSE-listed companies hits ₹400 trillion milestone
The Indian stock market's valuation crossed ₹400 trillion in a historic milestone on Monday, with the last ₹100 trillion rolling in the shortest duration of a mere 9 months, as the country's bright macroeconomic fundamentals encouraged local and foreign investors to plough more money into equities.
New Wipro CEO must cover a lot of ground
The sudden resignation of Thierry Delaporte as Wipro Ltd's chief executive officer is the last thing investors in the company want to deal with.
Synchron readies large-scale brain implant trial
Synchron Inc, a rival to Elon Musk's Neuralink brain implant startup, is preparing to recruit patients for a large-scale clinical trial required to seek commercial approval for its device, the company's chief executive told Reuters.
Alibaba slashes cloud prices globally as AI demand quickens
Alibaba Group Holding Ltd. is cutting prices for cloud customers from the US to Singapore by as much as 59%, mirroring deep discounts at home as the once high-flying division struggles to fend off rivals and revive growth.
Piramal Alternatives invests ₹110 cr in Biodeal Pharma
As contract manufacturing becomes the new A growth driver of the pharmaceutical industry, Piramal Alternatives, the fund management business of the Piramal Group, on Monday announced an investment of ₹110 crore in Biodeal Pharmaceuticals Ltd, a contract development and manufacturing organization.
